comparemela.com

Latest Breaking News On - Daniel stelter - Page 9 : comparemela.com

FOSS Patents: Compared to the EU s COVID VaxGate, Watergate was merely a transgression: two questions of life or death the EU can t answer satisfactorily

Wednesday, January 6, 2021 Compared to the EU s COVID VaxGate, Watergate was merely a transgression: two questions of life or death the EU can t answer satisfactorily I already mentioned in my first post this year about the EU s miserable failure to buy COVID-19 vaccines (as compared to the U.S., Canada, the UK, Israel, and Bahrain), primarily because the French government didn t want the EU to buy too many doses from non-French companies. That scandal now has a far higher profile, with two of the three parties in Merkel s governing coalition already having voiced criticism in public. Many politicians and reporters in other EU member states haven t understood the significance of this yet. Even France itself will suffer far more from the consequences of Macron s worst initiative than it ever stood to gain.

FOSS Patents: BioNTech

Wednesday, February 3, 2021 This post is a departure from my blog s industry focus that I wouldn t have contemplated if not for the highly unusual circumstances we re facing in the COVID-19 pandemic. The scientific aspects of pharmaceutical patents are above my head, but that also applies to the heads of those politicians proposing compulsory licensing of such patents in the current situation. I just became aware of a disconcerting statement by the chairman of the center-right European People s Party (EPP) group in the European Parliament, Manfred Weber MEP (Christian Social Union, CSU), quoted in a German newspaper article (my translation): If need be, admitted vaccines must also be made by others on the basis of compulsory licensing.

FOSS Patents: Vaccines

Wednesday, January 6, 2021 I already mentioned in my first post this year about the EU s miserable failure to buy COVID-19 vaccines (as compared to the U.S., Canada, the UK, Israel, and Bahrain), primarily because the French government didn t want the EU to buy too many doses from non-French companies. That scandal now has a far higher profile, with two of the three parties in Merkel s governing coalition already having voiced criticism in public. Many politicians and reporters in other EU member states haven t understood the significance of this yet. Even France itself will suffer far more from the consequences of Macron s worst initiative than it ever stood to gain.

FOSS Patents: Sanofi

Wednesday, February 3, 2021 This post is a departure from my blog s industry focus that I wouldn t have contemplated if not for the highly unusual circumstances we re facing in the COVID-19 pandemic. The scientific aspects of pharmaceutical patents are above my head, but that also applies to the heads of those politicians proposing compulsory licensing of such patents in the current situation. I just became aware of a disconcerting statement by the chairman of the center-right European People s Party (EPP) group in the European Parliament, Manfred Weber MEP (Christian Social Union, CSU), quoted in a German newspaper article (my translation): If need be, admitted vaccines must also be made by others on the basis of compulsory licensing.

FOSS Patents: Ten patent and antitrust predictions for 2021

FOSS Patents: Ten patent and antitrust predictions for 2021
fosspatents.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fosspatents.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.